TipRanks
Assembly Biosciences (DE:V7B)
FRANKFURT:V7B
Germany Market
V7B
Assembly Biosciences
RESEARCH TOOLSreports

Assembly Biosciences (V7B) Income Statement

3 Followers

Assembly Biosciences Income Statement

Last quarter (Q2 2026), Assembly Biosciences's total revenue was $13.37M, an increase of 38.94% from the same quarter last year. In Q2, Assembly Biosciences's net income was $-3.86M. See Assembly Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 72.30M$ 28.52M$ 7.16M$ 0.00$ 6.25M
Gross Profit
$ 72.17M$ -27.41M$ -41.74M$ -69.08M$ 6.25M
Operating Expenses
$ 84.42M$ 18.01M$ 22.91M$ 25.03M$ 138.94M
Depreciation and Amortization
$ 129.00K$ 129.00K$ 450.00K$ 498.00K$ 466.00K
EBITDA
$ -5.99M$ -39.72M$ -60.74M$ -92.52M$ -90.58M
Operating Income
$ -12.12M$ -45.42M$ -64.65M$ -94.11M$ -132.69M
Other Income/Expenses
$ 6.00M$ 5.57M$ 3.45M$ 1.02M$ 302.00K
Pretax Income
$ -6.12M$ -39.85M$ -61.20M$ -93.09M$ -132.39M
Net Income
$ -6.12M$ -40.18M$ -61.23M$ -93.09M$ -129.85M
Per Share Metrics
Basic EPS
$ -0.55$ -6.69$ -13.38$ -22.82$ -36.00
Diluted EPS
$ -0.55$ -6.69$ -13.38$ -22.82$ -36.00
Weighted Average Shares Outstanding
 11.21M 6.00M 4.58M 4.03M 3.61M
Weighted Average Shares Outstanding (Diluted)
 11.21M 6.00M 4.58M 4.03M 3.61M
Currency in USD

Assembly Biosciences Earnings and Revenue History